Logo do repositório

Expression of MicroRNAs in Adults with Celiac Disease: A Narrative Review

dc.contributor.authorRigo, Francielen Furieri [UNESP]
dc.contributor.authorOliveira, Ellen Cristina Souza de [UNESP]
dc.contributor.authorQuaglio, Ana Elisa Valencise
dc.contributor.authorMoutinho, Bruna Damásio
dc.contributor.authorDi Stasi, Luiz Claudio [UNESP]
dc.contributor.authorSassaki, Ligia Yukie [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.contributor.institutionBotucatu Technology Park
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.date.accessioned2025-04-29T18:06:16Z
dc.date.issued2024-09-01
dc.description.abstractCeliac disease (CD) is an immune-mediated enteropathy triggered by the ingestion of proline- and glutamine-rich proteins, widely termed “gluten”, in genetically susceptible individuals. CD induces an altered immune response that leads to chronic inflammation and duodenal mucosal damage. Currently, there are no specific tests for the accurate diagnosis of CD, and no drugs are available to treat this condition. The only available treatment strategy is lifelong adherence to a gluten-free diet. However, some studies have investigated the involvement of microRNAs (miRNAs) in CD pathogenesis. miRNAs are small noncoding ribonucleic acid molecules that regulate gene expression. Despite the growing number of studies on the role of miRNAs in autoimmune disorders, data on miRNAs and CD are scarce. Therefore, this study aimed to perform a literature review to summarize CD, miRNAs, and the potential interactions between miRNAs and CD in adults. This review shows that miRNA expression can suppress or stimulate pathways related to CD pathogenesis by regulating cell proliferation and differentiation, regulatory T-cell development, innate immune response, activation of the inflammatory cascade, focal adhesion, T-cell commitment, tissue transglutaminase synthesis, and cell cycle. Thus, identifying miRNAs and their related effects on CD could open new possibilities for diagnosis, prognosis, and follow-up of biomarkers.en
dc.description.affiliationDepartment of Internal Medicine Medical School São Paulo State University (UNESP), SP
dc.description.affiliationVerum Ingredients Botucatu Technology Park, SP
dc.description.affiliationDepartment of Gastroenterology Division of Clinical Gastroenterology and Hepatology University of São Paulo School of Medicine (USP), SP
dc.description.affiliationLaboratory of Phytomedicines Pharmacology and Biotechnology (PhytoPharmaTec) Department of Biophysics and Pharmacology Institute of Biosciences São Paulo State University (UNESP), SP
dc.description.affiliationUnespDepartment of Internal Medicine Medical School São Paulo State University (UNESP), SP
dc.description.affiliationUnespLaboratory of Phytomedicines Pharmacology and Biotechnology (PhytoPharmaTec) Department of Biophysics and Pharmacology Institute of Biosciences São Paulo State University (UNESP), SP
dc.identifierhttp://dx.doi.org/10.3390/ijms25179412
dc.identifier.citationInternational Journal of Molecular Sciences, v. 25, n. 17, 2024.
dc.identifier.doi10.3390/ijms25179412
dc.identifier.issn1422-0067
dc.identifier.issn1661-6596
dc.identifier.scopus2-s2.0-85204109368
dc.identifier.urihttps://hdl.handle.net/11449/297332
dc.language.isoeng
dc.relation.ispartofInternational Journal of Molecular Sciences
dc.sourceScopus
dc.subjectbiomarkers
dc.subjectceliac disease
dc.subjectgluten-free diet
dc.subjectimmune response
dc.subjectmicroRNAs
dc.titleExpression of MicroRNAs in Adults with Celiac Disease: A Narrative Reviewen
dc.typeResenhapt
dspace.entity.typePublication
relation.isOrgUnitOfPublicationa3cdb24b-db92-40d9-b3af-2eacecf9f2ba
relation.isOrgUnitOfPublication.latestForDiscoverya3cdb24b-db92-40d9-b3af-2eacecf9f2ba
unesp.author.orcid0000-0001-5357-3468[2]
unesp.author.orcid0000-0002-7864-1073[5]
unesp.author.orcid0000-0002-7319-8906[6]
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatupt

Arquivos